ASCENDIS PHARMA A/S - ADR (ASND) Institutional Ownership Changes & 13F Activity
ASCENDIS PHARMA A/S - ADR (ASND). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Ra Capital Management, L.P., Avoro Capital Advisors Llc, Fmr Llc, Janus Henderson Group Plc, and Artisan Partners Limited Partnership.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Neuberger Berman Group Llc | Sell | -21,049 | -100.0% | 0 | $0.00 | Q4 2025 | Oct 27, 2026 |
| Catalio Capital Management, Lp | Buy | +119,265 | — | 119,265 | $25.43M | Q4 2025 | Sep 02, 2026 |
| Advisors Asset Management, Inc. | Sell | -10,609 | -100.0% | 0 | $0.00 | Q4 2025 | Aug 26, 2026 |
| Ensign Peak Advisors, Inc | Sell | -1,164 | -1.6% | 69,560 | $14.83M | Q4 2025 | Aug 18, 2026 |
| Seven Fleet Capital Management Lp | Buy | +5,670 | — | 5,670 | $1.21M | Q4 2025 | Feb 26, 2026 |
| Bell Investment Advisors, Inc | Buy | +52 | — | 52 | $11.09K | Q4 2025 | Feb 24, 2026 |
| Dorsey Wright & Associates | Buy | +8,504 | — | 8,504 | $1.81M | Q4 2025 | Feb 20, 2026 |
| Corient Private Wealth Llc | Buy | +3,393 | — | 3,393 | $723.52K | Q4 2025 | Feb 19, 2026 |
| Raymond James Financial Inc | Buy | +6,662 | — | 6,662 | $1.42M | Q4 2025 | Feb 18, 2026 |
| Vident Advisory, Llc | Buy | +1,926 | — | 1,926 | $410.70K | Q4 2025 | Feb 18, 2026 |
| Mercer Global Advisors Inc | Buy | +1,058 | — | 1,058 | $225.61K | Q4 2025 | Feb 18, 2026 |
| Newedge Advisors, Llc | Buy | +90 | — | 90 | $19.19K | Q4 2025 | Feb 18, 2026 |
| Ra Capital Management, L.P. | Buy | +10,281,496 | — | 10,281,496 | $2.19B | Q4 2025 | Feb 17, 2026 |
| Avoro Capital Advisors Llc | Buy | +5,111,111 | — | 5,111,111 | $1.09B | Q4 2025 | Feb 17, 2026 |
| Fmr Llc | Buy | +4,153,311 | — | 4,153,311 | $885.65M | Q4 2025 | Feb 17, 2026 |
| Janus Henderson Group Plc | Buy | +4,061,641 | — | 4,061,641 | $866.10M | Q4 2025 | Feb 17, 2026 |
| Artisan Partners Limited Partnership | Buy | +3,225,885 | — | 3,225,885 | $687.89M | Q4 2025 | Feb 17, 2026 |
| Wellington Management Group Llp | Buy | +1,762,721 | — | 1,762,721 | $375.88M | Q4 2025 | Feb 17, 2026 |
| Price T Rowe Associates Inc | Buy | +1,570,260 | — | 1,570,260 | $334.84M | Q4 2025 | Feb 17, 2026 |
| Perceptive Advisors Llc | Buy | +1,081,421 | — | 1,081,421 | $230.60M | Q4 2025 | Feb 17, 2026 |
| T. Rowe Price Investment Management, Inc. | Buy | +1,080,224 | — | 1,080,224 | $230.35M | Q4 2025 | Feb 17, 2026 |
| Ameriprise Financial Inc | Buy | +550,477 | — | 550,477 | $117.38M | Q4 2025 | Feb 17, 2026 |
| Citadel Advisors Llc | Buy | +519,516 | — | 519,516 | $110.78M | Q4 2025 | Feb 17, 2026 |
| Nomura Asset Management International Inc. | Buy | +496,837 | — | 496,837 | $105.95M | Q4 2025 | Feb 17, 2026 |
| Fil Ltd | Buy | +478,641 | — | 478,641 | $102.07M | Q4 2025 | Feb 17, 2026 |
| Susquehanna International Group, Llp | Buy | +470,951 | — | 470,951 | $100.43M | Q4 2025 | Feb 17, 2026 |
| Spyglass Capital Management Llc | Buy | +415,549 | — | 415,549 | $88.61M | Q4 2025 | Feb 17, 2026 |
| Polar Capital Holdings Plc | Buy | +370,473 | — | 370,473 | $79.00M | Q4 2025 | Feb 17, 2026 |
| Fred Alger Management, Llc | Buy | +352,109 | — | 352,109 | $75.08M | Q4 2025 | Feb 17, 2026 |
| Alliancebernstein L.P. | Buy | +288,592 | — | 288,592 | $61.54M | Q4 2025 | Feb 17, 2026 |
Frequently asked questions about ASND activity
Which institutional owners are buying ASND?
Institutional owners buying ASND include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ASND activity?
"Buy" means an investor increased their reported position in ASND compared to the prior reporting period. This reflects growing exposure to ASCENDIS PHARMA A/S - ADR (ASND) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ASND increasing?
Institutional interest in ASND can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related ASND Institutional Insights
- ASND Overview
- ASND 13F Institutional Holders
- ASND Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ASND Insider Trading & SEC Form 4 Activity
- ASND Articles
- Top Institutional Investor Stock Rankings